small molecule

PALONOSETRON HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand name	PALONOSETRON HYDROCHLORIDE
Active ingredient	PALONOSETRON HYDROCHLORIDE
Strength	EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Dosage form	INJECTABLE
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	September 2018
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.